Phase II proof-of-concept trial of ESN 364 in women with endometriosis

Trial Profile

Phase II proof-of-concept trial of ESN 364 in women with endometriosis

Planning
Phase of Trial: Phase II

Latest Information Update: 19 Dec 2013

At a glance

  • Drugs Fezolinetant (Primary)
  • Indications Endometriosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2013 This trial is planned to start in quarter 4, 2014, according to a Euroscreen media release.
    • 19 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top